首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
间叶系细胞之增殖拮抗阻碍剂
摘要
本发明乃提供含有由构成基因显现启动子(promoter)的TGAGTCA或TGACTCA而成的AP-l核酸(AP-1 nucleotide)的间叶系细胞之增殖拮抗阻碍剂,可供慢性风湿性关节炎起首的弥漫性胶原病(diffuse cllagen disease)之治疗剂用途。
申请公布号
TW321604
申请公布日期
1997.12.01
申请号
TW082109114
申请日期
1993.11.02
申请人
殟槷俊一
发明人
殟槷俊一
分类号
A61K31/70
主分类号
A61K31/70
代理机构
代理人
洪武雄 台北巿城中区武昌街一段六十四号八楼;陈灿晖 台北巿城中区武昌街一段六十四号八楼
主权项
1.一种间叶系细胞之增殖拮抗阻碍用医药组成物,其特征为含有由构成基因显现启动子之TGAGTCA或TGACTCA而成AP-1核酸者。2.一种治疗胶原病之医药组成物,其特征为由申请专利范围第1项之拮抗阻碍用医药组成物而构成者。3.如申请专利范围第2项之医药组成物,系提供慢性风湿性关节炎的治疗剂用途者。
地址
日本
您可能感兴趣的专利
FACIAL MASK AND METHOD OF MAKING
SYSTEMS AND METHODS FOR ADMINISTERING PULMONARY MEDICATIONS
IMPLANTABLE BLOOD PUMP
SUCTION CLEANING DEVICE
Acrylic Bone Cement Having a Delayed Release Polymerization Inhibitor such as an Anti-Oxidant For Increased Working Time
REMOVABLE INSERT CONTAINING SCENTED MATERIAL
METHOD OF TREATING CANCER
MODIFIED RELEASE OF 4-METHYL-3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]-N-[5-(4-METHYL-1H-IMIDAZOL-1-YL)-3-(TRIFLOUOROMETHYL)PHENYL] BENZAMIDE SOLUBILIZED USING ORGANIC ACIDS
METHODS OF INDUCING AN IMMUNE RESPONSE WITH COMPOSITIONS COMPRISING A NEISSERIA MENINGITIDIS 741 PROTEIN
AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS
USE OF DEGARELIX IN THE TREATMENT OF ENDOMETRIOSIS AND RELATED DISEASES
PROBIOTIC COMPOSITION FOR ORAL HEALTH
In Vivo and Ex Vivo Expansion of Hematopoietic Stem Cells With a Targeted Combination of Clinically Tested, FDA Approved Drugs
USE OF CHROMIUM HISTIDINATE FOR TREATMENT OF CARDIOMETABOLIC DISORDERS
COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS
Dosing and Administration of Oligonucleotide Cancer Therapies
METHODS, COMPOSITIONS, AND FORMULATIONS FOR PREVENTING OR REDUCING ADVERSE EFFECTS IN A PATIENT
USE OF GLYCEROPHOSPHOINOSITOLS FOR THE TREATMENT OF SEPTIC SHOCK
EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF
EXTREMELY HIGH LOADING DOSE